Quick Answer
RECURSION PHARMACEUTICALS, INC. reported Stockholders Equity of $1.13 billion for fiscal year 2025.
RECURSION PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.13B | +9.3% |
| 2024 | $1.03B | +123.3% |
| 2023 | $463.44M | -4.6% |
| 2022 | $485.81M | -10.5% |
| 2021 | $542.94M | +363.2% |
| 2020 | -$206.29M | -66.0% |
| 2019 | -$124.27M | -94.6% |
| 2018 | -$63.85M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.05B | +99.6% | +13.9% |
| June 30, 2025 | $919.15M | +57.3% | -1.6% |
| March 31, 2025 | $933.95M | +132.8% | -9.7% |
| December 31, 2024 | $1.03B | +123.3% | +97.3% |
| September 30, 2024 | $524.56M | +19.8% | -10.2% |
| June 30, 2024 | $584.45M | +24.6% | +45.7% |
| March 31, 2024 | $401.15M | -6.7% | -13.4% |
| December 31, 2023 | $463.44M | -4.6% | +5.8% |
- RECURSION PHARMACEUTICALS, INC. showed an increase of +9.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, RECURSION PHARMACEUTICALS, INC.’s stockholders equity has grown by 1871.2% (from -$63.85 million to $1.13 billion).
- The most recent figure is from RECURSION PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: